Cargando…

Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift

SIMPLE SUMMARY: Brain metastases (BMs) are common among patients with advanced HER2 breast cancer. The recent introduction of systemic therapy with central nervous system activity as well as the wider use of brain stereotactic radiotherapy (SRT) are contributing to improving the outcomes for these p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ippolito, Edy, Silipigni, Sonia, Matteucci, Paolo, Greco, Carlo, Carrafiello, Sofia, Palumbo, Vincenzo, Tacconi, Claudia, Talocco, Claudia, Fiore, Michele, D’Angelillo, Rolando Maria, Ramella, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946529/ https://www.ncbi.nlm.nih.gov/pubmed/35326665 http://dx.doi.org/10.3390/cancers14061514

Ejemplares similares

BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients
por: Ippolito, Edy, et al.
Publicado: (2023)

COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases()
por: Ippolito, Edy, et al.
Publicado: (2020)

Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system
por: Ippolito, Edy, et al.
Publicado: (2018)

Preventing Cardiotoxicity in Personalized Breast Irradiation
por: Ippolito, Edy, et al.
Publicado: (2023)

Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series
por: Ippolito, Edy, et al.
Publicado: (2022)

A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients
por: Ramella, Sara, et al.
Publicado: (2018)

Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results
por: Ramella, Sara, et al.
Publicado: (2013)

Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer
por: Fiore, Michele, et al.
Publicado: (2015)

Radiation-Induced Pneumonitis in the Era of the COVID-19 Pandemic: Artificial Intelligence for Differential Diagnosis
por: Giordano, Francesco Maria, et al.
Publicado: (2021)

Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01)
por: Fiore, Michele, et al.
Publicado: (2021)

Can we prevent COVID-19 from causing victims among uninfected cancer patients?()
por: Ramella, Sara, et al.
Publicado: (2020)

The psychological impact of the covid-19 pandemic on radiotherapy cancer patients
por: Vicinanza, Flavia, et al.
Publicado: (2022)

Estimation of patient setup uncertainty using BrainLAB Exatrac X‐Ray 6D system in image‐guided radiotherapy
por: Infusino, Erminia, et al.
Publicado: (2015)

42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis
por: Ramella, S., et al.
Publicado: (2021)

Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer
por: Fiore, Michele, et al.
Publicado: (2017)

Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?
por: Ricci, Angela Dalia, et al.
Publicado: (2021)

Achieving equity for children and adolescents with perinatal HIV exposure: an urgent need for a paradigm shift
por: Mutanga, Jane Namangolwa, et al.
Publicado: (2023)

Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!
por: Høilund-Carlsen, Poul Flemming, et al.
Publicado: (2018)

Paradigm Shift to Neuroimmunomodulation for Translational Neuroprotection in Stroke
por: Amantea, Diana, et al.
Publicado: (2018)

The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria
por: Bottero, Marta, et al.
Publicado: (2021)

Responder analyses for anti-amyloid immunotherapies for Alzheimer’s disease: a paradigm shift by regulatory authorities is urgently needed
por: Salemme, Simone, et al.
Publicado: (2023)

Paradigm Shift or Shifting Paradigm for Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2012)

Targeting Her2/neu in uterine serous carcinoma: A paradigm shift in management
por: Lopez, Salvatore, et al.
Publicado: (2018)

Brain metastases management paradigm shift: A case report and review of the literature
por: REFAAT, TAMER, et al.
Publicado: (2016)

Shifting Sugars and Shifting Paradigms
por: Siegal, Mark L.
Publicado: (2015)

Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases
por: Shinde, Ashwin, et al.
Publicado: (2019)

A paradigm shift
Publicado: (2009)

PO-1505 Phone call triage for patients admission in a radiotherapy department during COVID 19 pandemic
por: Santo, B., et al.
Publicado: (2021)

Paradigm shift : the new promise of information technology
por: Tapscott, Don, 1947-
Publicado: (1993)

Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study †
por: Ciabattoni, Antonella, et al.
Publicado: (2022)

Paradigm Shift in Life Sciences
por: Kim, Kisoon
Publicado: (2018)

Paradigm shift: cognitive surgery
por: Kenngott, Hannes G., et al.
Publicado: (2017)

The Shifting Paradigm of Health Care
por: Hooper, Vallire D.
Publicado: (2020)

Heparins: A Shift of Paradigm
por: Hemker, H. Coenraad, et al.
Publicado: (2019)

Justification of the Proposed Paradigm Shift
por: Walther, Cornelia C.
Publicado: (2020)

RAD: A Paradigm, Shifting
por: Williams, John W
Publicado: (2021)

Shifting the Paradigm on Cannabis Safety
por: Bannigan, Pauric, et al.
Publicado: (2022)

Paradigm Shift in Spinal Surgery
por: Kim, Hyeun-Sung, et al.
Publicado: (2023)

FK506-binding protein 51 is a possible novel tumoral marker
por: Romano, S, et al.
Publicado: (2010)

Dynomics: A Novel and Promising Approach for Improved Breast Cancer Prognosis Prediction
por: Inglese, Marianna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c8h1cuedcdlalms2lfl1gdvped